Obstructive Sleep Apnea: Using Orofacial Myofunctional Therapy as a Part of a FxMed Approach to Treatment
Obstructive Sleep Apnea is a condition affecting up to 22 million Americans and close to 1 billion people worldwide.
This condition can have serious impacts on overall health and has been shown to be a contributing factor to:
and chronic headaches
There are a variety of treatment options available to manage Obstructive Sleep Apnea including Positive Airway Pressure devices (the most common being CPAP), dental mandibular advancement appliances, and various surgeries, but there are also functional treatment approaches that can target the underlying causes of the disease.